Meta-analysis

The answer to what is a meta-analysis is a statistical method that combines compatible results from multiple studies into one weighted estimate. A systematic review finds and appraises the studies; meta-analysis is the optional math afterward. Done well, it sharpens an answer. Done badly, it gives weak evidence a very tidy decimal point.

What does a meta-analysis actually do?

A meta-analysis converts results from studies asking the same focused question into a common measure, then calculates a pooled estimate and its uncertainty. The studies are not usually treated as equal votes. Larger or more precise studies generally receive more weight, so the result is closer to a weighted average than a show of hands.

Suppose five randomized controlled trials test the same supplement against placebo but reach slightly different estimates. A meta-analysis can express each trial on the same scale, assign statistical weights, and produce one summary effect with a confidence interval. A forest plot often shows each study as a line and the combined estimate as a diamond. The diamond is not a sixth study. It is the calculation built from the five already there.

That is the useful meta analysis meaning behind phrases such as “pooled result” or “quantitative synthesis.” In pooled analysis, studies contribute compatible numbers to a shared estimate; researchers should not simply pour unlike outcomes, populations, and study designs into one statistical bucket.

What is meta-analysis vs systematic review?

The meta-analysis vs systematic review difference is process versus calculation. A systematic review uses a planned method to search for every eligible study, select studies by stated rules, assess their risk of bias, and summarize what the full evidence base says. A meta-analysis is the statistical step that may combine the compatible numerical results found by that review.

The practical systematic review definition therefore includes the search and appraisal even when no numbers are pooled. Some reviews end with a narrative synthesis because the studies measured different outcomes, involved populations too unlike one another, or supplied too little usable data. That restraint can be better science than forcing a summary number.

A meta-analysis should usually sit inside a systematic review, but the labels are not interchangeable. “Systematic review and meta-analysis” means the authors did both jobs. “Systematic review” alone does not promise a pooled estimate, and “meta-analysis” on a title does not prove that the search was complete or the included evidence was sound.

Why can a meta-analysis still be wrong?

A meta-analysis can be wrong because statistics cannot repair biased, poorly designed, selectively published, or fundamentally mismatched studies. Cochrane warns that pooled results can seriously mislead when study design, within-study bias, differences between studies, and reporting bias are not handled carefully. More participants on paper do not erase the flaws inside the original trials.

This is the garbage-in, garbage-out rule. Ten weak studies do not become one strong study after pooling. A narrow confidence interval can make an answer look precise while the underlying research asks slightly different questions or systematically misses negative findings. Precision answers “how tightly did this model estimate the pooled effect?” It does not answer “were the inputs true?”

Three checks matter before trusting the diamond:

• Study quality: Were the underlying trials randomized, controlled, adequately blinded, and honestly reported?
• Compatibility: Are the participants, interventions, comparators, and outcomes similar enough that combining them makes scientific sense?
• Missing evidence: Could unpublished or selectively reported results tilt the available record toward a positive answer?

The model matters too. Fixed-effect and random-effects methods make different assumptions about whether the studies estimate one shared effect or a distribution of related effects. Neither setting is a truth button. Good authors explain the choice, show variation between studies, and test whether reasonable analytical changes overturn the conclusion.

Where does meta-analysis sit on the evidence ladder?

A good meta-analysis of strong human trials can sit at the top of an evidence ladder because it evaluates the full research record and estimates an effect more precisely than one trial can. The method label alone does not earn that rank. A meta-analysis of animal experiments remains animal evidence; a pooled set of biased human studies remains biased human evidence.

Molecular Reference therefore grades the inputs as well as the wrapper. The evidence-tier glossary identifies the kind of evidence behind a claim, while the full evidence-grading method asks what the studies measured, how well they were run, and whether the result applies to people. “Meta-analysis” is a reason to read more closely, not permission to stop reading.

This distinction matters for peptides. Many research peptides do not yet have enough comparable human trials to pool. A review that combines rodent experiments cannot move a claim into the human-RCT tier, however polished its forest plot looks. The honest tier follows the subjects and designs in the included studies.

What does a real meta-analysis look like for creatine?

Creatine offers a concrete human example because multiple controlled trials exist and researchers can pool comparable outcomes. A 2024 systematic review screened 1,694 records, assessed 67 full texts, and included 12 studies of adults younger than 50 in its meta-analysis of creatine with resistance training. The researchers pooled changes in lean body mass and body fat rather than treating “fitness” as one vague outcome.

The review estimated that creatine plus resistance training increased lean body mass by 1.14 kg more than training alone, with a 95% confidence interval from 0.69 to 1.59 kg. The paper also reported its risk-of-bias assessment: 52% of included studies were rated low risk, 41% had some concerns, and 7% were high risk. That audit belongs beside the headline number.

Creatine shows why pooled analysis studies can be useful: separate trials become a clearer estimate, while the review still exposes the condition of the evidence underneath. The pooled result is stronger than cherry-picking the friendliest trial. It is not stronger than its search, eligibility rules, bias checks, and included studies allow.